what are glp 1 drugs GLP-1 Drugs: Fighting Diabetes and Weight Gain💊 - General Is GLP-1 Safe for Weight

In the STEP trials, semaglutide 2.4mg weekly resulted in mean weight reductions of 1517% over 68 weeks, whilst tirzepatide in the SURPASS trials showed reductions of 1520% (Kushner et al

Explore 24/7 messaging or support models to address questions and side effects promptly

And in the comparison between phentermine and GLP-1 medications, the numbers tell a story that is difficult to argue with

doi: 10.3389/fragi.2025.1691007 Received 22 August 2025 Revised 30 October 2025 Accepted 06 November 2025 Published 27 November 2025 Volume 6 - 2025 Edited by Kieran Reid, Harvard Medical School, United States Reviewed by Shannon Hernon, Harvard Medical School, United States Nicole Bajdek, Harvard Medical School, United States Updates Copyright 2025 Dinkla, Beavers, Robbins, Akpalu, Wherry, Miller, Beavers, Espinoza, Trejo, Stepanenko and Cortes

This class of medications is now recommended as the top priority for patients with established cardiovascular disease or indicators of high risk

Controlled Substances Act (CSA) places drugs into schedules (I-V) based on their potential for abuse, dependence, and accepted medical use